| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |